Polyphenol composition and method of its use and manufacture in the treatment of metabolic disorders
The invention provides a polyphenolic composition and method for its use and manufacture in the treatment of metabolic disorders. The active agents of the composition can include flavonoids and anthocyanins. The active agents can be obtained from rose petal extract, including Rosa multiflora rose petal extract. The composition finds use in the treatment of obesity and complications associated with obesity.
1. A method of reducing body weight, comprising administering to an obese subject an effective amount of a composition comprising a supercritical fluid red rose petal extract, wherein said extract comprises about 3.50 w/w % isoquercetin and about 0.30 w/w % quercetin, and wherein administering said composition reduces body weight in said subject.
2. The method of claim 1 , wherein said extract comprises about 66.0 w/w % polyphenols, about 9.5 w/w % flavonoids, and about 2.7 w/w % anthocyanins.
3. The method of claim 1 , wherein said extract comprises 66.44±3.09 w/w % polyphenols, 9.47±1.23 w/w % flavonoids, and 2.73±0.38 w/w % anthocyanins.
4. The method of claim 1 , wherein said extract comprises about 0.30 w/w % rutin.
5. The method of claim 1 , wherein said extract comprises 3.48±0.11 w/w % isoquercetin, 0.25±0.28 w/w % quercetin, 0.33±0.02 w/w % rutin, or combinations thereof.
6. The method of claim 1 , wherein said extract comprises at least one phenolic acid.
7. The method claim 1 , wherein said extract comprises about 0.30 w/w % ethyl gallate, about 1.90 w/w % ellagic acid, about 0.02 w/w % methyl gallate, about 0.10 w/w % catechin, about 1.40 w/w % gallic acid, about 0.10 w/w % 3,4-dihydroxy benzoic acid, or combinations thereof.
8. The method of claim 1 , wherein said extract comprises 0.28±0.04 w/w % ethyl gallate, 1.85±0.33 w/w % ellagic acid, 0.02±0.003 w/w % methyl gallate, 0.11±0.008 w/w % catechin, 1.41±0.04 w/w % gallic acid, 0.09±0.01 w/w % 3,4-dihydroxy benzoic acid, or combinations thereof.
9. The method of claim 1 , wherein said extract comprises at least one chlorogenic acid.
10. The method of claim 1 , wherein said extract comprises 0.00046±0.0001 w/w % 3-O-caffeoylquinic acid (3-CQA), 0.0114±0.006 w/w % 5-O-Caffeoylquinic acid (5-CQA), 0.0104±0.004 w/w % 4-O-Caffeoylquinic acid (4-CQA), 0.022±0.008 w/w % 3,4 Di-O-caffeoylquinic acid (3,4-DiCQA), 0.388±0.14 w/w % 3,5 Di-O-caffeoylquinic acid (3,5-DiCQA), and 0.0823±0.01 w/w % 4,5 Di-O-caffeoylquinic acid (4,5-DiCQA), or combinations thereof.
11. The method of claim 1 , wherein said extract comprises 3.5 w/w % isoquercetin, 1.8-2.0 w/w % ellagic acid, 1.0-1.5 w/w % gallic acid, 0.3-0.35 w/w % rutin, 0.25 w/w % quercetin, 0.1 w/w % catechins, or combinations thereof.
12. The method of claim 1 , wherein said composition inhibits pancreatic lipase.
13. The method of claim 1 , wherein said composition has an IC50 for pancreatic lipase of about 81.4 μg/Ml.
14. The method of claim 1 , wherein said composition inhibits α-glucosidase.
15. The method of claim 1 , wherein said composition has an IC50 for α-glucosidase of about 1.33 μg/Ml.
16. The method of claim 1 , wherein said composition has an IC50 for nitric oxide scavenging activity of about 213.3 μg/Ml.
17. The method of claim 1 , wherein said composition has a radical scavenging activity of about 89% at a concentration of 100 μg/ml as determined by DPPH assay.
18. The method of claim 1 , wherein said composition has a superoxide scavenging activity of about 82.8% at 100 μg/ml.
19. The method of claim 1 , wherein said supercritical fluid rose petal extract is supercritical fluid Rosa multiflora rose petal extract.
20. The method of claim 1 , wherein said subject has a metabolic disorder selected from the group consisting of prediabetes, diabetes, type 1 diabetes, type 2 diabetes, dyslipidemia, hyperglycemia, and combinations thereof.
21. The method of claim 1 , wherein said composition is administered orally, buccally, sub-lingually, parenterally, intravenously, intravaginally, rectally, by inhalation, or combinations thereof.
22. The method of claim 1 , wherein said composition is in a form selected from the group consisting of a powder, liquid, pill, tablet, pellet, capsule, thin film, solution, spray, syrup, linctus, lozenge, pastille, chewing gum, paste, vapor, suspension, emulsion, ointment, cream, lotion, liniment, gel, drop, topical patch, buccal patch, bead, gummy, gel, sol, injection, and combinations thereof.
23. The method of claim 1 , wherein said supercritical fluid is carbon dioxide.